ST. PAUL, Minn.--(BUSINESS WIRE)--Transoma Medical, the leader in implantable wireless monitoring systems for biomedical research, announced that it has received Food and Drug Administration 510(k) marketing clearance for its SleuthTM Electrocardiogram Monitoring System, the first wireless, implantable heart monitor for human applications. Sleuth monitors heart activity 24/7 to provide accurate, timely diagnostic data for evaluating cardiac arrhythmias and other serious conditions, which often lead to infrequent, unexplained syncope (fainting).
